iCo Therapeutics Inc $ 0.09 0.0077 (9.64%)
Volume:
184,950
Avg Vol (1m):
119,240
Market Cap $:
12.63 Mil
Enterprise Value $:
12.50 Mil
PE Ratio:
0.00
PB Ratio:
0.00
Financial Strength |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Piotroski F-Score | 3 | ||
Altman Z-Score | 0 | ||
Beneish M-Score | -13.05 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -690.07 | ||
ROA % | -156.42 | ||
ROC (Joel Greenblatt) % | -31339.29 | ||
3-Year EBITDA Growth Rate | 5.6 |
ICOTF
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
EV-to-EBIT | -9.56 | ||
EV-to-EBITDA | -9.57 | ||
Current Ratio | 0.58 | ||
Quick Ratio | 0.58 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -22.1 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Earnings Yield (Greenblatt) % | -10.49 |